{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T06:32:06Z","timestamp":1770273126792,"version":"3.49.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004324","name":"Astellas Pharma US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004324","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.jaad.2009.03.044","type":"journal-article","created":{"date-parts":[[2009,10,9]],"date-time":"2009-10-09T07:10:38Z","timestamp":1255072238000},"page":"1044-1055","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Treatment of psoriasis in patients with hepatitis C: From the Medical Board of the National Psoriasis Foundation"],"prefix":"10.1016","volume":"61","author":[{"given":"Amylynne J.","family":"Frankel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abby S.","family":"Van Voorhees","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvia","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil J.","family":"Korman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark G.","family":"Lebwohl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Bruce F.","family":"Bebo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice B.","family":"Gottlieb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2009.03.044_bib1","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.jaad.2004.05.013","article-title":"Etanercept therapy for patients with psoriatic arthritis and concurrent hepatitis C virus infection: report of 3 cases","volume":"51","author":"Magliocco","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl","key":"10.1016\/j.jaad.2009.03.044_bib2","doi-asserted-by":"crossref","first-page":"ii18","DOI":"10.1136\/ard.2004.028209","article-title":"Safety of antitumor necrosis factor (anti-TNF) therapy in patients with chronic viral infections: hepatitis C, hepatitis B, and HIV infection","volume":"63","author":"Calabrese","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2009.03.044_bib3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2004.11.025","article-title":"Etanercept as an adjuvant to interferon and ribavirin in treatment-naive patients with chronic hepatitis C virus infection: a phase 2 randomized, double-blind, placebo-controlled study","volume":"42","author":"Zein","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.jaad.2009.03.044_bib4","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1752-1947-1-86","article-title":"Extensive psoriasis induced by pegylated interferon: a case report","volume":"1","author":"Citro","year":"2007","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.jaad.2009.03.044_bib5","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/pmj.76.896.365","article-title":"Extensive psoriasis induced by interferon alfa treatment for chronic hepatitis C","volume":"76","author":"Taylor","year":"2000","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.jaad.2009.03.044_bib6","series-title":"Methotrexate [package insert]","year":"2005"},{"key":"10.1016\/j.jaad.2009.03.044_bib7","series-title":"Neoral (cyclosporine) [package insert]","year":"2002"},{"key":"10.1016\/j.jaad.2009.03.044_bib8","series-title":"Soriatane [package insert]","year":"1997"},{"key":"10.1016\/j.jaad.2009.03.044_bib9","series-title":"Enbrel (etanercept) [package insert]","year":"2004"},{"key":"10.1016\/j.jaad.2009.03.044_bib10","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0190-9622(80)80187-3","article-title":"Toxic hepatitis from oral methoxsalen photochemotherapy (PUVA)","volume":"3","author":"Pariser","year":"1980","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.03.044_bib11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0049-0172(86)90020-X","article-title":"Cytotoxic drugs: their clinical application to the rheumatic diseases","volume":"15","author":"Clements","year":"1986","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jaad.2009.03.044_bib12","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/00004836-199312000-00010","article-title":"Fulminant hepatic failure after methotrexate and PUVA therapy for psoriasis","volume":"17","author":"Markin","year":"1993","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jaad.2009.03.044_bib13","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/1523-1747.ep12500067","article-title":"Complications in methotrexate treatment of psoriasis with particular reference to liver fibrosis","volume":"79","author":"Ashton","year":"1982","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2009.03.044_bib14","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.clindermatol.2004.06.013","article-title":"The life-threatening complications of dermatologic therapies","volume":"23","author":"Orion","year":"2005","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jaad.2009.03.044_bib15","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1136\/bmj.318.7183.593","article-title":"Clinical guidelines: developing guidelines","volume":"318","author":"Shekelle","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.jaad.2009.03.044_bib16","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1365-2133.2005.06423.x","article-title":"Treatment of psoriasis with alefacept in patients with hepatitis C infection: a report of two cases","volume":"152","author":"Thaci","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2009.03.044_bib17","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s10067-006-0412-1","article-title":"Combination therapy with cyclosporine A and anti-TNF-alpha agents in the treatment of rheumatoid arthritis and concomitant hepatitis C virus infection","volume":"26","author":"Bellisai","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jaad.2009.03.044_bib18","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1111\/j.1365-2133.2007.07873.x","article-title":"Ciclosporin treatment of psoriasis in a patient with chronic hepatitis C","volume":"156","author":"Imafuku","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2009.03.044_bib19","first-page":"18","article-title":"The role of topical therapy for patients with extensive psoriasis","volume":"79","author":"Feldman","year":"2007","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2009.03.044_bib20","first-page":"188","article-title":"Topical management of psoriasis\u2013corticosteroids and sparing corticosteroid therapy","volume":"14","author":"Gorgievska Sukarovska","year":"2006","journal-title":"Acta Dermatovenerol Croat"},{"key":"10.1016\/j.jaad.2009.03.044_bib21","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1001\/archderm.138.8.1071","article-title":"UV-B phototherapy clears psoriasis through local effects","volume":"138","author":"Dawe","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2009.03.044_bib22","first-page":"642","article-title":"Recent advances in phototherapy","volume":"10","author":"Simon","year":"2000","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2009.03.044_bib23","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1600-0781.1996.tb00201.x","article-title":"Effects of phototherapy on the production of cytokines by peripheral blood mononuclear cells and on systemic antibody responses in patients with psoriasis","volume":"12","author":"Jones","year":"1996","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.jaad.2009.03.044_bib24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0190-9622(86)70005-4","article-title":"Liver biopsies from patients with psoriasis related to photochemotherapy (PUVA): findings before and after 1 year of therapy in twelve patients; a blind study and review of literature on hepatotoxicity of PUVA","volume":"14","author":"Nyfors","year":"1986","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.03.044_bib25","doi-asserted-by":"crossref","first-page":"268","DOI":"10.2340\/0001555559268270","article-title":"Liver biopsy in PUVA-treated patients","volume":"59","author":"Zachariae","year":"1979","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2009.03.044_bib26","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2340\/0001555559371372","article-title":"Liver injury following administration of 8-methoxypsoralen during PUVA therapy","volume":"59","author":"Bjellerup","year":"1979","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2009.03.044_bib27","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0190-9622(81)80264-2","article-title":"Toxic hepatitis after PUVA","volume":"4","author":"Bjellerup","year":"1981","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.03.044_bib28","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1365-2133.1985.tb15269.x","article-title":"Chronic active hepatitis associated with etretinate therapy","volume":"112","author":"Weiss","year":"1985","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2009.03.044_bib29","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2340\/0001555565359362","article-title":"Differential hepatotoxicity of two oral retinoids (etretinate and isotretinoin) in a patient with palmoplantar psoriasis","volume":"65","author":"Vahlquist","year":"1985","journal-title":"Acta Derm Venereol"},{"issue":"Suppl","key":"10.1016\/j.jaad.2009.03.044_bib30","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/S0190-9622(08)80257-5","article-title":"Long-term safety of retinoid therapy","volume":"27","author":"Vahlquist","year":"1992","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl","key":"10.1016\/j.jaad.2009.03.044_bib31","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/S0190-9622(99)70359-2","article-title":"Acitretin in psoriasis: an overview of adverse effects","volume":"41","author":"Katz","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.03.044_bib32","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0190-9622(99)80058-9","article-title":"Effects of acitretin on the liver","volume":"41","author":"Roenigk","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.03.044_bib33","first-page":"4","article-title":"Psoriasis and hepatitis C treated with anti-TNF alpha therapy (etanercept)","volume":"12","author":"Cecchi","year":"2006","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.jaad.2009.03.044_bib34","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jaad.2005.05.043","article-title":"Etanercept monotherapy for a patient with psoriasis, psoriatic arthritis, and concomitant hepatitis C infection","volume":"54","author":"Rokhsar","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.03.044_bib35","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.jaad.2005.11.1035","article-title":"Etanercept therapy in two patients with psoriasis and concomitant hepatitis C","volume":"54","author":"De Simone","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.03.044_bib36","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/rheumatology\/kel191","article-title":"Etanercept treatment for three months is safe in patients with rheumatological manifestations associated with hepatitis C virus","volume":"46","author":"Marotte","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaad.2009.03.044_bib37","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1002\/art.21949","article-title":"Concomitant interferon-alpha therapy and tumor necrosis factor alpha inhibition for rheumatoid arthritis and hepatitis C","volume":"54","author":"Niewold","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2009.03.044_bib38","first-page":"1353","article-title":"Effective etanercept treatment for psoriatic arthritis complicating concomitant human immunodeficiency virus and hepatitis C virus infection","volume":"34","author":"Linardaki","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2009.03.044_bib39","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1136\/ard.62.11.1078","article-title":"Effect of tumor necrosis factor alpha antagonists on serum transaminases and viremia in patients with rheumatoid arthritis and chronic hepatitis C infection","volume":"62","author":"Peterson","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2009.03.044_bib40","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1093\/rheumatology\/kel123","article-title":"Safety of\u00a0anti-TNF-alpha therapy in rheumatoid arthritis and spondylarthropathies with concurrent B or C chronic hepatitis","volume":"45","author":"Roux","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaad.2009.03.044_bib41","first-page":"107","article-title":"Infliximab therapy for rheumatic diseases in patients with chronic hepatitis B or C","volume":"31","author":"Oniankitan","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2009.03.044_bib42","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1572-0241.2007.01131.x","article-title":"Successful treatment of chronic hepatitis C with pegylated interferon, ribavirin, and infliximab in a patient with Crohn's disease","volume":"102","author":"Abdelmalek","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaad.2009.03.044_bib43","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s10067-006-0394-z","article-title":"Inhibition of TNFalpha does not induce viral reactivation in patients with chronic hepatitis C infection: two cases","volume":"26","author":"Aslanidis","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jaad.2009.03.044_bib44","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/09546630310020470","article-title":"Etanercept therapy in patients with autoimmunity and hepatitis C","volume":"14","author":"Khanna","year":"2003","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2009.03.044_bib45","first-page":"472","article-title":"Treatment of psoriatic arthritis and rheumatoid arthritis with disease modifying drugs\u2013comparison of drugs and adverse reactions","volume":"35","author":"Helliwell","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2009.03.044_bib46","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1365-2249.2005.02859.x","article-title":"Immune effects of therapy with adalimumab in patients with rheumatoid arthritis","volume":"141","author":"Vigna-Perez","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaad.2009.03.044_bib47","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1053\/jlts.2002.35852","article-title":"Impact of immunosuppressive therapy on recurrence of hepatitis C","volume":"8","author":"Everson","year":"2002","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jaad.2009.03.044_bib48","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1016\/j.transproceed.2006.08.055","article-title":"Hepatitis C virus recurrence after liver transplantation: influence of immunosuppressive regimens on viral load and liver histology","volume":"38","author":"Oton","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jaad.2009.03.044_bib49","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.transproceed.2006.02.069","article-title":"Does cyclosporine have a beneficial effect on the course of chronic hepatitis C infection after renal transplantation?","volume":"38","author":"Kamar","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jaad.2009.03.044_bib50","series-title":"South","author":"Raptiva [package insert]","year":"2005"},{"key":"10.1016\/j.jaad.2009.03.044_bib51","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/01.TP.0000114610.40412.C6","article-title":"Effect of antimetabolite immunosuppressants on flaviviridae, including hepatitis C virus","volume":"77","author":"Stangle","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.jaad.2009.03.044_bib52","doi-asserted-by":"crossref","first-page":"S209","DOI":"10.1111\/j.1432-2277.1998.tb01117.x","article-title":"Searching for the optimal management of hepatitis C patients after liver transplantation","volume":"1","author":"Platz","year":"1998","journal-title":"Transplant Int"},{"key":"10.1016\/j.jaad.2009.03.044_bib53","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1053\/j.gastro.2006.08.027","article-title":"Mycophenolic acid inhibits hepatitis C virus replication and acts in synergy with cyclosporin A and interferon-alpha","volume":"131","author":"Henry","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaad.2009.03.044_bib54","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1097\/TP.0b013e3181722f3a","article-title":"Impact of immunosuppressive regimen on survival of kidney transplant recipients with hepatitis C","volume":"85","author":"Luan","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.jaad.2009.03.044_bib55","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1136\/bmj.320.7240.963","article-title":"Systematic review of comparative efficacy and tolerability of calcipotriol in treating chronic plaque psoriasis","volume":"320","author":"Ashcroft","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.jaad.2009.03.044_bib56","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1001\/archderm.134.9.1101","article-title":"Topical tacrolimus is not effective in chronic plaque psoriasis. A pilot study","volume":"134","author":"Zonneveld","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2009.03.044_bib57","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jaad.2004.07.011","article-title":"Tacrolimus ointment is effective for facial and intertriginous psoriasis","volume":"51","author":"Lebwohl","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.03.044_bib58","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.jaad.2004.06.010","article-title":"Pimecrolimus cream 1% in the treatment of intertriginous psoriasis: a double-blind, randomized study","volume":"51","author":"Gribetz","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.03.044_bib59","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1046\/j.1365-2133.2002.04996.x","article-title":"A randomized, observer-blinded trial of twice vs three times weekly narrowband ultraviolet B phototherapy for chronic plaque psoriasis","volume":"147","author":"Cameron","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2009.03.044_bib60","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJM197412052912301","article-title":"Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light","volume":"291","author":"Parrish","year":"1974","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2009.03.044_bib61","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/archderm.1976.01630310005001","article-title":"Photochemotherapy for psoriasis with orally administered methoxsalen","volume":"112","author":"Wolff","year":"1976","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2009.03.044_bib62","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2340\/00015555577376","article-title":"Treatment of resistant psoriasis with oral 8-methoxypsoralen and long-wave ultraviolet light (PUVA): A treatment schedule and a follow-up study","volume":"57","author":"Weismann","year":"1977","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"10.1016\/j.jaad.2009.03.044_bib63","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/1523-1747.ep12496022","article-title":"Oral methoxsalen photochemotherapy for the treatment of psoriasis: a cooperative clinical trial","volume":"68","author":"Melski","year":"1977","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2009.03.044_bib64","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/lt.20222","article-title":"Impact of tacrolimus versus cyclosporine in hepatitis C virus-infected liver transplant recipients on recurrent hepatitis: a prospective, randomized trial","volume":"10","author":"Martin","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jaad.2009.03.044_bib65","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.intimp.2004.01.018","article-title":"Cyclosporine reduces hepatic antioxidant capacity: protective roles of antioxidants","volume":"4","author":"Durak","year":"2004","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jaad.2009.03.044_bib66","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1053\/j.gastro.2006.08.027","article-title":"Mycophenolic acid inhibits hepatitis C virus replication and acts in synergy with cyclosporin A and interferon-alpha","volume":"131","author":"Henry","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaad.2009.03.044_bib67","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1053\/jlts.2003.50003","article-title":"Lack of antiviral effect of a short course of mycophenolate mofetil in patients with chronic hepatitis C virus infection","volume":"9","author":"Firpi","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jaad.2009.03.044_bib68","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1097\/00007890-200003150-00055","article-title":"Changes in hepatitis C virus RNA viremia concentrations in long-term renal transplant patients after introduction of mycophenolate mofetil","volume":"69","author":"Rostaing","year":"2000","journal-title":"Transplantation"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096220900396X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096220900396X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:15:27Z","timestamp":1759270527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019096220900396X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":68,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S019096220900396X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2009.03.044","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of psoriasis in patients with hepatitis C: From the Medical Board of the National Psoriasis Foundation","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2009.03.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}